Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

Jie Du, Xiaonan Wang, Christiane Miereles, James L. Bailey, Richard Debigaré, Bin Zheng, S. Russ Price, William E. MitchJournal of Clinical Investigation 2004 · DOI

Abstract

With trauma, sepsis, cancer, or uremia, animals or patients experience accelerated degradation of muscle protein in the ATP-ubiquitin-proteasome (Ub-P’some) system. The initial step in myofibrillar proteolysis is unknown because this proteolytic system does not break down actomyosin complexes or myofibrils, even though it degrades monomeric actin or myosin. Since cytokines or insulin resistance are common in catabolic states and will activate caspases, we examined whether caspase-3 would break down actomyosin. We found that recombinant caspase-3 cleaves actomyosin, producing a characteristic, approximately 14-kDa actin fragment and other proteins that are degraded by the Ub-P’some. In fact, limited actomyosin cleavage by caspase-3 yields a 125% increase in protein degradation by the Ub-P’some system. Serum deprivation of L6 muscle cells stimulates actin cleavage and proteolysis; insulin blocks these responses by a mechanism requiring PI3K. Cleaved actin fragments are present in muscles of rats with muscle atrophy from diabetes or chronic uremia. Accumulation of actin fragments and the rate of proteolysis in muscle stimulated by diabetes are suppressed by a caspase-3 inhibitor. Thus, in catabolic conditions, an initial step resulting in loss of muscle protein is activation of caspase-3, yielding proteins that are degraded by the Ub-P’some system. Therapeutic strategies could be designed to prevent these events.

Introduction: The Mechanical Mystery of Muscle Wasting

Muscle atrophy—the debilitating loss of muscle mass—is a hallmark of catabolic states such as sepsis, cancer, and chronic kidney disease. While the ATP-ubiquitin-proteasome (Ub-P’some) system is known to be the primary driver of protein degradation, a significant mechanical hurdle exists: the Ub-P’some system cannot degrade intact actomyosin complexes or myofibrils. It requires an initial "bolt cutter" to disassemble these massive structures into smaller fragments that the proteasome can handle. This study identifies caspase-3 as that critical initiator.

Methods and Experimental Design

The researchers utilized a multi-tiered approach to validate this mechanism:

  1. Biochemical Reconstitution: Purified actomyosin was incubated with recombinant caspase-3 to observe direct cleavage.
  2. Cellular Modeling: L6 skeletal muscle cells were subjected to serum deprivation to simulate catabolic stress, with PI3K pathway manipulation to study insulin regulation.
  3. In Vivo Models: Rats with streptozotocin-induced diabetes or chronic uremia were studied to confirm physiological relevance in living organisms.
  4. Molecular Markers: Western blotting was used to identify a signature 14-kDa actin fragment as a specific biomarker of caspase-3 activity.

Key Insights: Caspase-3 as the Proteolytic Trigger

Traditionally associated with apoptosis (programmed cell death), caspase-3 plays a non-lethal but destructive role in muscle cells by initiating myofibril disassembly. Under normal conditions, insulin and IGF-1 stimulate the PI3K pathway, which keeps caspase-3 activation in check. In catabolic states, reduced PI3K activity unleashes caspase-3.

Figure 5: Caspase-3 activation and the accumulation of the 14-kDa actin fragment. (a) Increasing concentrations of staurosporine (Stau) lead to the appearance of the 12-kDa active caspase-3 subunit. (b) The 14-kDa actin fragment accumulates when caspase-3 is activated (Stau+) and is further stabilized by the proteasome inhibitor MG132, confirming it is a substrate for the Ub-P’some system.

A critical finding is the "two-step relay": caspase-3 performs limited proteolysis (disassembly), which subsequently increases the efficiency of the Ub-P’some system's degradation by approximately 125%.

Results: The 14-kDa Actin Fragment as a "Smoking Gun"

The identification of a specific 14-kDa actin fragment provides a clear biomarker for caspase-3-mediated muscle degradation across different models.

Figure 6: Identification of the 14-kDa actin fragment in purified systems and biological lysates. (a) Direct cleavage of purified actomyosin by caspase-3 produces the signature 14-kDa fragment. (b) The same fragment is detected in L6 cell lysates and psoas muscle lysates under catabolic conditions, confirming the mechanism in vivo.

Experimental results showed:

  • Direct Cleavage: Recombinant caspase-3 successfully breaks down actomyosin in vitro, producing the signature 14-kDa fragment.
  • In Vivo Confirmation: Muscles from diabetic and uremic rats exhibited significantly higher levels of the 14-kDa fragment compared to healthy controls.
  • Therapeutic Potential: Treatment with the caspase-3 inhibitor Ac-DEVD-CHO suppressed accelerated muscle protein loss in diabetic rats, suggesting a potential therapeutic pathway.

Discussion and Future Directions

While caspase-3 is a primary initiator in these models, the authors acknowledge that other proteases, such as calpains, might contribute in different disease contexts. The transition to clinical application requires overcoming the bioavailability challenges of current peptide-based inhibitors. However, the 14-kDa actin fragment holds significant promise as a clinical biomarker to monitor the severity of muscle wasting in real-time.

Summary updated

Abstract

With trauma, sepsis, cancer, or uremia, animals or patients experience accelerated degradation of muscle protein in the ATP-ubiquitin-proteasome (Ub-P’some) system. The initial step in myofibrillar proteolysis is unknown because this proteolytic system does not break down actomyosin complexes or myofibrils, even though it degrades monomeric actin or myosin. Since cytokines or insulin resistance are common in catabolic states and will activate caspases, we examined whether caspase-3 would break down actomyosin. We found that recombinant caspase-3 cleaves actomyosin, producing a characteristic, approximately 14-kDa actin fragment and other proteins that are degraded by the Ub-P’some. In fact, limited actomyosin cleavage by caspase-3 yields a 125% increase in protein degradation by the Ub-P’some system. Serum deprivation of L6 muscle cells stimulates actin cleavage and proteolysis; insulin blocks these responses by a mechanism requiring PI3K. Cleaved actin fragments are present in muscles of rats with muscle atrophy from diabetes or chronic uremia. Accumulation of actin fragments and the rate of proteolysis in muscle stimulated by diabetes are suppressed by a caspase-3 inhibitor. Thus, in catabolic conditions, an initial step resulting in loss of muscle protein is activation of caspase-3, yielding proteins that are degraded by the Ub-P’some system. Therapeutic strategies could be designed to prevent these events.
BibTeX
@article{du2004activation,
  author = {Jie Du and Xiaonan Wang and Christiane Miereles and James L. Bailey and Richard Debigaré and Bin Zheng and S. Russ Price and William E. Mitch},
  title = {{Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions}},
  journal = {Journal of Clinical Investigation},
  year = {2004},
  doi = {10.1172/jci200418330},
}
Figure